Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Understanding what you need to start zero based budgeting is crucial for success. Equip yourself with essential tools to manage your finances effectively.
23,851 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
May data show existing home sales rise to a 4.17 million SAAR, up 3.2% from April and year over year, as affordabilit...
Citadel announced the largest internship class in its history, yet only a tiny fraction of applicants were selected. ...
The Strait of Hormuz is finally reopening after months of disruption, but energy flows are far from back to normal. A...
SpaceX rolls out a $60 billion bid to acquire Cursor and back new silicon ventures, aiming to tilt the AI hardware la...
Oil’s plunge below already is forcing a rapid rethink of the Fed’s rate path as energy prices cool and inflation sign...
XRP faces renewed selling pressure as it tests critical support around $1.00, with bears signaling caution across bot...
AI stocks are pausing in an unusual air pocket, with Meta and Microsoft trading like bear-market bets. Analysts warn ...
Intel shares retreat after a rally fueled by Lip-Bu Tan’s turnaround plan, as investors await Q2 results and the AI d...
As the 2026 World Cup draws global attention, a bold CEO taps the frenzy to build lasting personal-finance products f...
A major housing policy nears passage, inviting a reshaping of manufactured housing. Analysts say the policy impact ig...
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...